Joshua R. Disbrow
2012 - Ampio Pharmaceuticals
In 2012, Joshua R. Disbrow earned a total compensation of $1.1M as Chief Operating Officer at Ampio Pharmaceuticals.
Compensation breakdown
| Option Awards | $1,038,937 |
|---|---|
| Salary | $11,375 |
| Total | $1,050,312 |
Disbrow received $1M in option awards, accounting for 99% of the total pay in 2012.
Disbrow also received $11.4K in salary.
Rankings
In 2012, Joshua R. Disbrow's compensation ranked 5,919th out of 11,487 executives tracked by ExecPay. In other words, Disbrow earned more than 48.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,919 out of 11,487 | 49th |
Division Manufacturing | 2,096 out of 4,253 | 51st |
Major group Chemicals And Allied Products | 522 out of 1,198 | 56th |
Industry group Drugs | 354 out of 920 | 62nd |
Industry Pharmaceutical Preparations | 279 out of 700 | 60th |
Source: SEC filing on August 15, 2014.
Disbrow's colleagues
We found four more compensation records of executives who worked with Joshua R. Disbrow at Ampio Pharmaceuticals in 2012.
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019